Skip to Main Content

Author Details

Xavier Maldonado
Hospital Universitari Vall d'Hebron
1994
47
13
PMIDPaper TitleJournal TitlePublished Year
36269935Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials.J Clin Oncol2023
37639648Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.J Clin Oncol2023
37453915Novel Approaches in the Systemic Management of High-Risk Prostate Cancer.Clin Genitourin Cancer2023
36436177Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus.Clin Transl Oncol2023
35050303Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.JAMA Oncol2022
35469702High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium.Eur Urol2022
35427469High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial.Lancet Oncol2022
35912190Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer.Front Oncol2022
35090339Bone health and therapeutic agents in advanced prostate cancer.Front Biosci (Landmark Ed)2022
35051385Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.Lancet Oncol2022
34256353PARP inhibitors in advanced prostate cancer: when to use them?Endocr Relat Cancer2021
33964325Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: Results from a phase III trial.Radiother Oncol2021
32203842The future of bladder cancer therapy: Optimizing the inhibition of the fibroblast growth factor receptor.Cancer Treat Rev2020
30694442The Challenge of Managing Bladder Cancer and Upper Tract Urothelial Carcinoma: A Review with Treatment Recommendations from the Spanish Oncology Genitourinary Group (SOGUG).Target Oncol2019
30321689Phase 2 Randomized Study of Radiation Therapy and 3-Year Androgen Deprivation With or Without Concurrent Weekly Docetaxel in High-Risk Localized Prostate Cancer Patients.Int J Radiat Oncol Biol Phys2019
30293231Consensus on management of castration-resistant prostate cancer on behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology.Clin Transl Oncol2019
29198640Serum Testosterone Levels in Prostate Cancer Patients Undergoing Luteinizing Hormone-Releasing Hormone Agonist Therapy.Clin Genitourin Cancer2018
29086250SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017).Clin Transl Oncol2018
28073027Epileptic features and survival in glioblastomas presenting with seizures.Epilepsy Res2017
27770397Intermittent versus continuous androgen deprivation therapy to biochemical recurrence after external beam radiotherapy: a phase 3 GICOR study.Clin Transl Oncol2017
27843413Effectiveness of radiotherapy for metastatic spinal cord compression in patients with short life expectancy.Rep Pract Oncol Radiother2017
27800640Free Testosterone During Androgen Deprivation Therapy Predicts Castration-Resistant Progression Better Than Total Testosterone.Prostate2017
25727526[Prostate cancer].Med Clin (Barc)2016
26621508Management of prostate cancer patients following radiation therapy after radical surgery referred from urology to radiation oncology departments in Spain.Clin Transl Oncol2016
27598804Late Radiation and Cardiovascular Adverse Effects After Androgen Deprivation and High-Dose Radiation Therapy in Prostate Cancer: Results From the DART 01/05 Randomized Phase 3 Trial.Int J Radiat Oncol Biol Phys2016
27743530Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope.Cancer Treat Rev2016
27207596Hormonal changes after localized prostate cancer treatment. Comparison between external beam radiation therapy and radical prostatectomy.Actas Urol Esp2016
26900365Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272].Rep Pract Oncol Radiother2016
25183050Androgen deprivation and radiotherapy in patients with prostate cancer and cardiovascular risk factors: clinical controversies.Clin Transl Oncol2015
26489387Prognostic implications of epilepsy in glioblastomas.Clin Neurol Neurosurg2015
26065609Correction to Lancet Oncol 2015; 16: 324. High-dose radiotherapy with shortterm or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial.Lancet Oncol2015
26109913Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance.Rep Pract Oncol Radiother2015
25702876High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial.Lancet Oncol2015
23650874Role of immunotherapy in castration-resistant prostate cancer (CRPC).BJU Int2014
24866537Non-metastatic castration-resistant prostate cancer (CPRCM0), an old scenario with renewed clinical interest.Actas Urol Esp2014
24682792Infrastructures, treatment modalities, and workload of radiation oncology departments in Spain with special attention to prostate cancer.Clin Transl Oncol2014
23606355Do patients with metastatic urothelial carcinoma benefit from docetaxel as second-line chemotherapy?Clin Transl Oncol2014
20555063Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol2010
20470711[Critical review of the use of radiotherapy as initial treatment of localized prostate cancer].Actas Urol Esp2010
20466614Treatment of localised prostate cancer with radiation therapy: evidence versus opinion.Clin Transl Oncol2010
20462840Bilateral testicular germ cell tumours: a single hospital experience.Clin Transl Oncol2010
17074674Thallium-201SPECT assessment in the detection of recurrences of treated gliomas and ependymomas.Clin Transl Oncol2006
945781431Phosphorus magnetic resonance spectroscopy in the assessment of head and neck tumors.Int J Radiat Oncol Biol Phys1998
9090966Fluorouracil and high-dose leucovorin with radiotherapy as adjuvant therapy for rectal cancer. Results of a phase II study.Acta Oncol1997
9020299Preoperative simultaneous chemoradiotherapy in locally advanced cancer of the oral cavity and oropharynx.Am J Clin Oncol1997
8570129Improving survival of medulloblastoma: results in two groups of patients.Oncology1996
7880867Time-related changes in functional activity of mouse spermatozoa during in vitro or in vivo incubation.J Exp Anim Sci1994
  • 1 - 47 of 47

Recommended Authors

William C Jackson
University of Michigan ann arbor
Career Start Year 2013
Number of shared co-authors 37
Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 15
Alan Dal Pra
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 11
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 3
Bridget F Koontz
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 18
Nicholas van As
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Career Start Year 2005
Number of shared co-authors 3
Ananya Choudhury
University of Manchester and The Christie NHS Foundation Trust
Career Start Year 2004
Number of shared co-authors 11
Amit Bahl
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 5
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 3
Eleni Efstathiou
Houston Methodist Cancer Center
Career Start Year 2000
Number of shared co-authors 10
Robert B Den
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 24
Mark K Buyyounouski
Stanford University
Career Start Year 1999
Number of shared co-authors 26
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 4
Evan Y Yu
University of Washington and Fred Hutchinson Cancer Research Center
Career Start Year 1997
Number of shared co-authors 11
Gert De Meerleer
University Hospitals Leuven
Career Start Year 1997
Number of shared co-authors 16
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Career Start Year 1995
Number of shared co-authors 17
Laurence Collette
Belgium International Drug Development Institute
Career Start Year 1995
Number of shared co-authors 19
Inge M van Oort
Radboud University Medical Center
Career Start Year 1995
Number of shared co-authors 10
William Robert Lee
Duke University School of Medicine
Career Start Year 1993
Number of shared co-authors 29
David I Quinn
USC Norris Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 4
Richard Choo
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 47
Fred Saad
University of Montreal Health Center
Career Start Year 1990
Number of shared co-authors 14
Celestia S Higano
University of Washington and Fred Hutchinson Cancer Research Center
Career Start Year 1987
Number of shared co-authors 12
Seth A Rosenthal
Sutter Cancer Centers Radiation Oncology Services
Career Start Year 1987
Number of shared co-authors 38
Peter Hoskin
Mount Vernon Cancer Centre
Career Start Year 1985
Number of shared co-authors 18
Maha Hussain
Northwestern University
Career Start Year 1984
Number of shared co-authors 12
Oliver Sartor
Tulane University School of Medicine
Career Start Year 1983
Number of shared co-authors 22
Mario A Eisenberger
Johns Hopkins University
Career Start Year 1977
Number of shared co-authors 18
Howard I Scher
Memorial Sloan Kettering Cancer Center
Career Start Year 1973
Number of shared co-authors 10
Alan Pollack
University of Miami Miller School of Medicine
Career Start Year 1963
Number of shared co-authors 24

Collaborators

Almudena Zapatero
University Hospital La Princesa
Co-authored papers 17
Araceli Guerrero
Hospital Son Espases
Co-authored papers 11
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 5
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 5
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 5
Michael L Steinberg
University of California los angeles
Co-authored papers 5
Ting Martin Ma
University of Washington
Co-authored papers 5
Amar U Kishan
University of California los angeles
Co-authored papers 5
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 5
Tahmineh Romero
David Geffen School of Medicine at university of california los angeles
Co-authored papers 5
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Co-authored papers 5
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Co-authored papers 4
Philippe Maingon
Pitie-Salpetriere Hospital, AP-HP.Sorbonne Universite
Co-authored papers 4
Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
Co-authored papers 4
Michel Bolla
universite Grenoble-Alpes (UGA)
Co-authored papers 4
James W Denham
University of Newcastle
Co-authored papers 3
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 3
David Joseph
Sir Charles Gairdner Hospital
Co-authored papers 3
Jordi Rodon
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Thomas M Pisansky
Mayo Clinic
Co-authored papers 3
Allison Steigler
University of Newcastle
Co-authored papers 3
Michael Xiang
University of California los angeles
Co-authored papers 2
Jesus E Juarez
University of California Los Angeles
Co-authored papers 2
Soumyajit Roy
Rush University Medical Center
Co-authored papers 2
Luca F Valle
University of California los angeles
Co-authored papers 2
Robert T Dess
University of Michigan ann arbor
Co-authored papers 2
Brian J Davis
Mayo Clinic
Co-authored papers 2
Joaquin Mateo
Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital Campus
Co-authored papers 2
Jeff M Michalski
Washington University School of Medicine
Co-authored papers 2
Jay P Ciezki
Cleveland Clinic
Co-authored papers 1
Release 1.2